A detailed history of Ethos Financial Group, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Ethos Financial Group, LLC holds 898 shares of BDX stock, worth $202,454. This represents 0.04% of its overall portfolio holdings.

Number of Shares
898
Previous 2,186 58.92%
Holding current value
$202,454
Previous $511,000 57.73%
% of portfolio
0.04%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$221.47 - $242.41 $285,253 - $312,224
-1,288 Reduced 58.92%
898 $216,000
Q2 2024

Aug 12, 2024

SELL
$225.07 - $246.17 $37,361 - $40,864
-166 Reduced 7.06%
2,186 $511,000
Q1 2024

May 08, 2024

BUY
$233.45 - $247.73 $7,470 - $7,927
32 Added 1.38%
2,352 $582,000
Q4 2023

Feb 07, 2024

SELL
$232.24 - $267.23 $6,502 - $7,482
-28 Reduced 1.19%
2,320 $566,000
Q3 2023

Nov 13, 2023

BUY
$254.9 - $283.59 $598,505 - $665,869
2,348 New
2,348 $607,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Ethos Financial Group, LLC Portfolio

Follow Ethos Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethos Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ethos Financial Group, LLC with notifications on news.